オリゴヌクレオチドベースの医薬品の可能性に、ようやくその価値に見合った注目が集まっています。Bachemは新たなイノベーションをもたらし、弊社顧客、ひいては患者様のクオリティ・オブ・ライフの向上に貢献します。
添付のデリバリーシステムである細胞透過性ペプチド(CPP)についての記事をぜひご参照ください。
Oligonucleotides are very promising and versatile therapeutics for rare and genetic diseases. They act on the RNA level through different molecular pathways that we already have described in a precedent article. Because of their mechanism of action, this class of therapeutics has huge possibilities to treat diseases that were incurable before. The use of oligonucleotide therapeutics is well tolerated by the body, selective to their target, and with reduced secondary effects. Despites their huge potential and attractiveness as a treatment, there is a major drawback when dealing with oligonucleotides as drugs: their poor bioavailability and cellular uptake. These aspects are the main limitations for their application as therapeutics. To address these drawbacks, it seems of utmost importance to develop delivery systems that enable oligonucleotides to reach their targets. In a previous article on oligonucleotide conjugates, we have described the use of the trimeric GalNAc (N-acetylgalactosamine) molecule as a carrier of oligonucleotides to specific cells, the hepatocytes. Here, we discuss a delivery system that have been in vogue since almost 40 years, the cell-penetrating peptides (CPP). The first use of CPP, a poly L-lysine, has been described for the delivery of an anticancer drug in vitro and in vivo of mouse model1. It has opened the way for generation of CPP-drug conjugates and has potential as well for oligonucleotides2.
- WEB展示場 TOP
- バッケムジャパン株式会社
- CELL-PENETRATING PEPTIDES: A DELIVERY SYSTEM FOR OLIGONUCLEOTIDES
企業情報
バッケムジャパン株式会社
- 住所東京都中央区日本橋堀留町1-9-10 上野ビル8階
- TEL03-6661-0774
- URLhttps://www.bachem.com/webinars/
その他の新着リリース
- ユーロフィン分析科学研究所株式会社 2024/08/30
-
コラム「【図説】メタバースの医療・ヘルスケアへの活用事例 ~VR/ARデバイスを認知症・外科手術の医療機器に進化させる海外企業の成功事例」をリリースしました
TechnoProducer株式会社 2024/08/30 -
材料内部での水分子の結びつき(水素結合) に新たな知見 ~水が関与する材料の機能発現メカニズム解明や、高性能材料の研究・技術開発に貢献~
株式会社東レリサーチセンター 2024/08/29 -
コラム「CRISPR Therapeutics(クリスパー・セラピューティクス)の経営戦略とは? ~ノーベル賞技術CRISPR-Cas9による細胞医療の革新」をリリースしました
TechnoProducer株式会社 2024/08/23 -
製造業(医薬品・医療機器)の活用シーンをご紹介!(文書デザイナー for GxP)
株式会社ユニオンシンク 2024/08/23